Virnich Daniel, CEO of Oncology Institute, Inc. ($TOI), made one open market purchase of common shares in the last 365 days, totaling $23,584. His most recent buy occurred on March 26, 2025. This ranks him 3,695th among nearly 5,000 insiders in our database by purchase amount, well below the average of $1.5 million across 3.29 transactions per insider. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Common Stock | 670608 | $0.00 | 2,458,758.0000 | 99,303,511 | 21.43% | 0.68% |
| March 27, 2026 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | J | Common Stock | 98534 | $3.07 | 2,360,224.0000 | 99,303,511 | 4.01% | 0.10% |
| March 17, 2026 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | J | Common Stock | 11834 | $3.59 | 1,788,150.0000 | 99,303,511 | 0.66% | 0.01% |
| Nov. 17, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Common Stock | 6464 | $0.00 | 1,799,984.0000 | 99,303,511 | 0.36% | 0.01% |
| Nov. 12, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Common Stock | 6211 | $0.00 | 1,793,520.0000 | 99,303,511 | 0.35% | 0.01% |
| May 21, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 20388 | $2.68 | 1,787,309.0000 | 90,661,800 | 1.13% | 0.02% |
| March 31, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Common stock | 1083334 | $0.00 | 1,807,697.0000 | 77,470,886 | 149.56% | 1.40% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | P | Common Stock | 22640 | $1.04 | 724,363.0000 | 77,470,886 | 3.23% | 0.03% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | P | Common Warrant | 11320 | $0.13 | 11,320.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 19, 2025 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 10261 | $0.89 | 701,723.0000 | 77,470,886 | 1.44% | 0.01% |
| Nov. 20, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 4977 | $0.14 | 711,984.0000 | 77,292,849 | 0.69% | 0.01% |
| Nov. 20, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 4750 | $0.14 | 716,961.0000 | 77,292,849 | 0.66% | 0.01% |
| Nov. 12, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | J | Common stock | 117142 | $0.00 | 721,711.0000 | 77,292,849 | 13.96% | 0.15% |
| Nov. 12, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | J | Common stock | 78094 | $0.00 | 838,853.0000 | 77,292,849 | 8.52% | 0.10% |
| May 21, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Common Stock | 198517 | $0.00 | 916,947.0000 | 76,046,694 | 27.63% | 0.26% |
| May 21, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common Stock | 11173 | $0.60 | 718,430.0000 | 76,046,694 | 1.53% | 0.01% |
| May 21, 2024 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | A | Non-Qualified Stock Option (right to buy) | 496293 | $0.00 | 496,293.0000 | 76,046,694 | 9999.99% | 0.65% |
| Nov. 21, 2023 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 4322 | $2.19 | 729,603.0000 | 73,265,621 | 0.59% | 0.01% |
| Nov. 14, 2023 | Oncology Institute, Inc. | $TOI | Virnich Daniel | Chief Executive Officer | D | Common stock | 4604 | $2.39 | 733,925.0000 | 73,265,621 | 0.62% | 0.01% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Virnich Daniel | President | A | Common stock | 114944 | $0.00 | 738,529.0000 | 73,265,621 | 18.43% | 0.16% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Virnich Daniel | President | A | Non-Qualified Stock Option (right to buy) | 287361 | $0.00 | 287,361.0000 | 73,265,621 | 9999.99% | 0.39% |